Submitted by melanie.kourba… on
Do not rely on Performance time for laboratory date fields
ASTP’s current approach is to use a single procedure performance date/time element in USCDI to cover all lab relevant date/time, which include: Specimen collection date/time; Specimen received date time; Test performed date/time; Report released date/time. APHL raises the concern that most systems don’t model specimen receipt as a procedure. APHL recommends at a minimum adding data elements to capture Specimen receipt at the lab date/time, Laboratory Test performed data/time, and Report released date/time.
Many of these dates are clinically relevant and important for CLIA accreditation, and having data elements within the EHR and LIMS with the appropriate specificity will enable a laboratory to meet these criteria more easily. Performance time can be broad, as in a surgery that can last multiple hours. In contrast, a specimen collection occurs at a specific moment in time, when the specimen physically leaves the body. To add complexity, the observation takes place at a later time, after the collection and when the specimen is in the laboratory. Nevertheless, it is necessary for CLIA for the laboratory to be able to map this information to what is contained in the EHR source system.
APHL is confident that most EHRs already track and have the capability to send Specimen Collection date/time, and so including it in USCDI V6 should not impose a burden on vendors.
An alternative name for this data element could be Performance time of the specimen collection.







Submitted by melanie.kourba… on
Add to USCDI with updated definition
APHL suggests elevating the level 0 data element "Specimen Received Date/Time" to USCDI with the definition: "The date/time when the testing laboratory received the specimen.”
APHL can offer multiple examples of use cases in which this data element would play a critical role, such as:
This information enables notification that a specimen is in the lab, which supports both patient treatment and laboratory workflows (e.g., labs know that an urgent test can now be worked on, physicians can avoid re-ordering a test or order an add-on test)
The time a specimen is received affects the evaluation of specimen acceptability and is also important for medicolegal chronology
This information is a CLIA required element (most important for the lab): Corresponds to CLIA element in §493.1242(b) in CLIA 42 CFR 493.1242 -- Standard: Specimen submission, handling, and referral (https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-493/subpart-K/subject-group-ECFR5f8f0b6639946fd/section-493.1242)
This element is used to determine turnaround time for lab testing. It is also used by public health as a proxy for the clinical temporal context when specimen collection date/time is not provided; it is collected in the LIS, not in the EHR.
APHL made similar comments in 2024 as part of the USCDI+ Laboratory Data Exchange Use Case, but ONC has not made these comments public yet.